Related Experiment Video
Updated: Feb 8, 2026
08:40
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
18.0K
Inhibiting Pri-miRNA Processing with Target Site Blockers.
Annita Louloupi1,2, Ulf Andersson Vang Ørom3
1Max Planck Institute for Molecular Genetics, Berlin, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|July 1, 2018
Summary
This study presents a novel method to block primary microRNA (pri-miRNA) processing in vivo. This technique allows for detailed investigation into miRNA biogenesis and its impact on gene regulation.
Area of Science:
- Molecular Biology
- Gene Regulation
- RNA Biology
Background:
- MicroRNA (miRNA) regulation is crucial for gene expression, with pri-miRNA processing significantly influencing final miRNA abundance.
- Understanding pri-miRNA biogenesis in vivo offers insights into individual miRNA contributions to gene regulation.
- Current RNA interference methods present challenges for specifically targeting pri-miRNA processing.
Purpose of the Study:
- To develop and detail a method for arresting specific pri-miRNA processing in vivo.
- To enable the study of pri-miRNA biogenesis and kinetics under various cellular conditions.
- To provide a versatile protocol applicable to different mammalian cell types.
Main Methods:
- Utilized locked nucleic acid (LNA) microRNA Target Site Blockers to inhibit pri-miRNA processing.
- Described a step-by-step protocol for in vivo application of LNA blockers.
- Demonstrated the method's applicability across diverse mammalian cell types.
Main Results:
- Successfully demonstrated a method to specifically arrest pri-miRNA processing in vivo.
- The protocol allows for the study of pri-miRNA processing kinetics under physiological conditions.
- The method is adaptable for use with different cell treatments, mutants, and cancer cell lines.
Conclusions:
- The developed LNA-based method provides a powerful tool for investigating pri-miRNA biogenesis.
- This approach overcomes limitations of existing RNA interference techniques for studying pri-miRNA processing.
- Facilitates in-depth analysis of miRNA regulatory roles and their impact on gene expression.
Related Concept Videos
00:46Feedback Inhibition
57.2K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
01:19Depolarizing Blockers: Pharmocokinetics
610
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
610
01:30Enzyme Inhibition
92.6K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.6K
01:28Depolarizing Blockers: Mechanism of Action
2.9K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.9K
02:34Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
01:28Drugs Acting on Autonomic Ganglia: Blockers
1.7K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K